HYEX
Healthy Extracts Inc.1.9900
-0.2200-9.95%
Dec 16, 4:00:00 PM EST
Earnings Call Transcripts
This Quarter (Q4 '25)
No earnings call transcript available yet
Last Quarter (Q3 '25)
No earnings call transcript available
Key Stats
Market Cap
33.57MP/E (TTM)
-Basic EPS (TTM)
-0.26Dividend Yield
0%Recent Filings
10-Q
Q3 FY2025 results
Healthy Extracts posted Q3 revenue of $918K, up 23% y/y from $745K, yet gross profit fell to $447K from $602K as COGS surged 230% y/y to $471K (51% of sales). Operating expenses climbed 75% y/y to $907K, mainly advertising and stock-based comp, driving a $395K net loss versus $354K profit last year; net trailed operating by fair-value gains on derivatives. Cash grew to $189K amid $203K YTD operating cash burn, backed by $299K net financing mainly related-party notes; total debt ~$1.7M. GUSA merger closed Oct 1 for 13.1M shares (77.5% ownership), booked as $23.5M long-term investment pending consolidation. Shares exploded from 3M to 16.9M. Integration delays pose risks.
8-K
Gummy USA merger finalized
Healthy Extracts Inc. completed its acquisition of Gummy USA LLC via merger on September 30, 2025, after rescinding an initial July purchase agreement. The deal issued 13,075,920 common shares to founder Donald Swanson, granting him 77.5% ownership plus anti-dilution rights against 154,306 options and warrants. Swanson steps in as CEO and Chairman, bringing gummy manufacturing expertise to bolster production capabilities. Leadership shuffled smoothly, yet integration details remain pending.
10-Q
Q2 FY2025 results
Healthy Extracts posted revenue of $968,656 for Q2 ended June 30, 2025, up 7% y/y from $908,389, with gross profit climbing 22% to $592,827 on a 39% margin versus 46% last year, thanks to efficiencies in the BergaMet health supplements segment. Yet operating expenses jumped 40% to $698,434, driven by higher advertising and consulting, yielding a slim $67,120 net income—down from $113,500—while YTD net loss narrowed to $331,739 from $747,758, or $(0.11) per diluted share on 3,050,879 shares, reconciling cleanly. Cash rose to $200,495, with $77,237 operating cash flow (derived) and $30,539 from financing, against $635,687 total debt including $247,423 convertible notes; free cash flow not disclosed in the 10-Q. Post-quarter, the firm closed a July 2025 acquisition of Gummy USA for 13,075,920 shares, recognizing no new goodwill per filing. Revenue growth persists.
8-K
Acquires Gummy USA, leadership shifts
Healthy Extracts Inc. acquired Gummy USA LLC on July 19, 2025, issuing 13,075,920 common shares—77.5% of its post-deal outstanding stock—to founder Donald Swanson, who became Chairman and President while prior President Kevin Pitts shifted to CEO. This deal hands control to Swanson, injecting his gummy supplement manufacturing expertise into the fold. Leadership realigns swiftly. Yet financials remain pending.
IPO
Employees
Sector
Industry
BIOE
Bio Essence Corp.
0.05+0.00
BSPK
Bespoke Extracts, Inc.
0.20+0.00
CVSI
CV Sciences, Inc.
0.03+0.00
EDXC
ENDEXX Corp.
0.00+0.00
HSTI
High Sierra Technologies Inc.
1.40+0.00
NTRR
Neutra Corp.
0.00+0.00
NXEN
Nexien BioPharma, Inc.
0.00+0.00
NXGB
NxGen Brands Inc.
0.00-0.00
PHBI
Pharmagreen Biotech Inc.
0.00+0.00
PLSH
Panacea Life Sciences Holdings,
0.09+0.00